Testosterone therapy may increase risk of cardiovascular disease in postmenopausal women
Testosterone therapy is not routinely recommended for postmenopausal women, in part because long-term safety data remain limited. It is, however, prescribed off label to help women suffering from low libido. A new study links testosterone therapy in postmenopausal women with a higher risk of incident cardiovascular disease. Results of the study were presented at the 2026 Annual Meeting of The…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Search for Alzheimer's drug unexpectedly finds possible biomarker
United Kingdom
-
Low daily step counts linked to dementia, Parkinson's and stroke
United Kingdom
-
Flavonoid found in citrus slows lung cancer cell growth in lab tests
United Kingdom
-
Q&A: Why does your prescription cost so much?
United Kingdom
-
Heart tests suggest astronauts could tolerate Mars' gravity after months in space
United Kingdom
-
Isle of Jersey Expands Marine Protections to Cover 21% of Territorial Waters
United Kingdom
-
Combined estrogen and testosterone therapy increases lumbar spine bone mineral density
United Kingdom
-
Premature menopause associated with higher insulin levels and greater CVD risk
United Kingdom